Brugada syndrome risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
The findings of Brugada syndrome are often concealed, but can be unmasked or modulated by a number of drugs and pathophysiological states including: | The findings of Brugada syndrome are often concealed, but can be unmasked or modulated by a number of drugs and pathophysiological states including: | ||
*[[Sodium channel blockers]] | *[[Sodium channel blockers]] | ||
*[[Procainamide]] | |||
*[[Fever]] | *[[Fever]] | ||
*[[Vagotonic agents]] that mimic sleep | *[[Vagotonic agents]] that mimic sleep | ||
Revision as of 01:03, 14 October 2012
|
Brugada syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Brugada syndrome risk factors On the Web |
|
American Roentgen Ray Society Images of Brugada syndrome risk factors |
|
Risk calculators and risk factors for Brugada syndrome risk factors |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Risk Factors: Agents and Scenarios that Provoke the Brugada Syndrome Pattern
The findings of Brugada syndrome are often concealed, but can be unmasked or modulated by a number of drugs and pathophysiological states including:
- Sodium channel blockers
- Procainamide
- Fever
- Vagotonic agents that mimic sleep
- Tricyclic antidepressants
- Cocaine
- Propranolol intoxication
Risk Statification
- Patients with syncope and an abnormal Type 1 ECG are at higher risk
- Asymptomatic patients at risk can be identified
- Presence of spontaneous Type 1 ST-segment elevation
- Characteristics of the S wave
- Presence of late potentials
- Inducibility of VT/VF using PES.